about
Preventing 30-day hospital readmissions: a systematic review and meta-analysis of randomized trialsUncovering treatment burden as a key concept for stroke care: a systematic review of qualitative researchRethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illnessStroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burdenQualitative systematic reviews of treatment burden in stroke, heart failure and diabetes - methodological challenges and solutionsUnderstanding patients' experiences of treatment burden in chronic heart failure using normalization process theory.Randomised controlled trial of azithromycin in smokers with asthma.A conceptual model of treatment burden and patient capacity in stroke.Examining patterns of multimorbidity, polypharmacy and risk of adverse drug reactions in chronic obstructive pulmonary disease: a cross-sectional UK Biobank study.Multimorbidity and co-morbidity in atrial fibrillation and effects on survival: findings from UK Biobank cohort.Minimally disruptive medicine: the evidence and conceptual progress supporting a new era of healthcare.Risk factors and mortality associated with multimorbidity in people with stroke or transient ischaemic attack: a study of 8,751 UK Biobank participants.Multimorbidity: what next?The LAST Word on Coaching as a Stroke Intervention?Systematic review of patient-reported measures of treatment burden in strokeWhat helps and hinders the provision of healthcare that minimises treatment burden and maximises patient capacity? A qualitative study of stroke health professional perspectives
P50
Q27011452-946E69FC-C323-4DCD-ABB4-F798FA62F25BQ28681098-38006A40-98AB-4D09-8E2E-11FD1680DC56Q33840905-3E228E79-56EA-4D59-9825-6D05260D4D66Q34451824-B15F9A8D-4C56-44F0-BC6F-0E3DE92BEB39Q34565245-A5F191A5-E240-412F-A8BC-98F4568CC30FQ34958077-5D96A6C5-928A-4927-995D-0320FA711374Q42925651-52008653-EBA0-4551-8DE0-15F9F640749CQ47349041-62F14E3E-310F-40BC-96E9-84310A54E6B6Q47555997-640871DF-C670-4368-BA45-8AB92B439906Q47616826-9CAF413A-D322-4461-9D9E-5DE530928AC9Q53618503-9B1E9A84-AEEB-4C89-8877-7AB87220BBC5Q55305252-3DD95E92-2139-42A6-ABF1-1D15885604C3Q88156826-4C298B1E-D9E5-4B0A-8778-68868CC1D599Q89749005-0E56BCA7-114D-4284-A3DF-6B55F24DF435Q90167180-AEEBED39-66CC-400E-A2DE-134400A25E38Q90469125-093E74D6-AE2C-45F3-8460-118E0A32D686
P50
description
researcher, ORCID id # 0000-0001-8620-8758
@en
wetenschapper
@nl
name
Katie Gallacher
@ast
Katie Gallacher
@en
Katie Gallacher
@es
Katie Gallacher
@nl
type
label
Katie Gallacher
@ast
Katie Gallacher
@en
Katie Gallacher
@es
Katie Gallacher
@nl
prefLabel
Katie Gallacher
@ast
Katie Gallacher
@en
Katie Gallacher
@es
Katie Gallacher
@nl
P106
P21
P31
P496
0000-0001-8620-8758